← All organizations

ArriVent BioPharma

For profit

Also known as: ArriVent BioPharm | ArriVent BioPharma | ArriVent BioPharma, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Dec 31, 2025

Timeline

2020s

Jun 1, 2021
ArriVent BioPharma— Founded

Drugs by trial phase (1 distinct, 4 trials)

Phase 3 (1 own, 0 via acquisition)

furmonertinib

Recent trials (7)

NCT07185997OfficialPhase 3Dec 31, 2025
NCT07185997Lead sponsorPhase 3Dec 31, 2025
NCT07010419CollaboratorPhase 3May 28, 2025
NCT05607550Study directorPhase 3Dec 15, 2022
NCT05607550Lead sponsorPhase 3Dec 15, 2022
NCT05364073Lead sponsorPhase 1Jun 30, 2022
NCT05364073Study directorPhase 1Jun 30, 2022

Details

Founded: Newtown Square, PA, US Jun 1, 2021
Last known activity: Dec 31, 2025